RESUMEN
ß-hydroxy-ß-methyl butyrate (HMB) is a bioactive metabolite derived from the amino acid leucine, usually applied for muscle mass increase during physical training, as well as for muscle mass maintenance in debilitating chronic diseases. The hypothesis of the present study is that HMB is a safe supplement for muscle mass gain by strength training. Based on this, the objective was to measure changes in body composition, glucose homeostasis and hepatic metabolism of HMB supplemented mice during strength training. Two of four groups of male mice (n = 6/group) underwent an 8-week training period session (climbing stairs) with or without HMB supplementation (190 mg/kgBW per day). We observed lower body mass gain (4.9 ± 0.43% versus 1.2 ± 0.43, p < 0.001) and increased liver mass (40.9 ± 0.9 mg/gBW versus 44.8 ± 1.3, p < 0.001) in the supplemented trained group compared with the non-supplemented groups. The supplemented trained group had an increase in relative adipose tissue mass (12.4 ± 0.63 mg/gBW versus 16.1 ± 0.88, P < 0.01) compared to the non-supplemented untrained group, and an increase in fasting blood glucose (111 ± 4.58 mg/dL versus 122 ± 3.70, P < 0.05) and insulin resistance (3.79 ± 0.19 % glucose decay/min versus 2.45 ± 0.28, P < 0.05) comparing with non-supplemented trained group. Adaptive heart hypertrophy was observed only in the non-supplemented trained group (4.82 ± 0.05 mg/gBW versus 5.12 ± 0.13, P < 0.05). There was a higher hepatic insulin-like growth factor-1 expression (P = 0.002) in supplemented untrained comparing with non-supplemented untrained group. Gene expression of gluconeogenesis regulatory factors was increased by training and reduced by HMB supplementation. These results confirm that HMB supplementation associated with intensive training protocol drives changes in glucose homeostasis and liver metabolism in mice.
Asunto(s)
Suplementos Dietéticos , Glucosa/metabolismo , Homeostasis/efectos de los fármacos , Músculo Esquelético , Valeratos/metabolismo , Animales , Glucosa/química , Humanos , Hígado , Masculino , Ratones , Músculo Esquelético/anatomía & histología , Músculo Esquelético/fisiología , Valeratos/químicaRESUMEN
Chemical investigation of the 90% acetone extract of the branches and leaves of Sabina gaussenii led to the isolation of two new cinnamyl isovalerate derivatives (1-2) and eighteen known compounds (3-20). Their structures were determined mainly by means of MS, 1D- and 2D-NMR data, and this is the first time these compounds have been reported from this plant. The biological activity test results indicated that the 90% acetone extract showed cytotoxicity against the human lung adenocarcinoma (A549) cell line (IC50 = 0.98 ± 0.1 µg/mL), compound 6 showed cytotoxicities against human cervical carcinoma (HeLa) (IC50 = 0.4 ± 0.1 µM ) and human gastric carcinoma (BGC-823) (IC50 = 0.9 ± 0.2 µM) cancer cell lines, and compound 19 showed cytotoxicities against HeLa (IC50 = 1.5 ± 0.4 µM), BGC-823 (IC50 = 7.0 ± 0.8 µM ), and A549 (IC50 = 10.6 ± 1.5 µM ) cancer cell lines.
Asunto(s)
Antineoplásicos Fitogénicos/aislamiento & purificación , Cinamatos/aislamiento & purificación , Cupressaceae/química , Extractos Vegetales/química , Valeratos/aislamiento & purificación , Antineoplásicos Fitogénicos/química , China , Cinamatos/química , Ensayos de Selección de Medicamentos Antitumorales , Células HeLa , Humanos , Estructura Molecular , Hojas de la Planta/química , Valeratos/químicaRESUMEN
Trichothecene 3-O-acetyltransferase (TRI101) is an indispensable enzyme for the biosynthesis of trichothecenes, a group of mycotoxins produced by Fusarium graminearum. In this study, an inhibitor of TRI101 was identified by chemical array analysis using compounds from the RIKEN Natural Products Depository (NPDepo) library. Although the addition of the identified enzyme inhibitor to the fungal culture did not inhibit trichothecene production, it can serve as a candidate lead compound in the development of a mycotoxin inhibitor that inactivates fungal defense mechanisms.
Asunto(s)
Acetiltransferasas/antagonistas & inhibidores , Evaluación Preclínica de Medicamentos/métodos , Inhibidores Enzimáticos/farmacología , Inhibidores Enzimáticos/química , Factores de Tiempo , Valeratos/química , Valeratos/farmacologíaRESUMEN
The present study focuses on predicting the concentration of intracellular storage polymers in enhanced biological phosphorus removal (EBPR) systems. For that purpose, quantitative image analysis techniques were developed for determining the intracellular concentrations of PHA (PHB and PHV) with Nile blue and glycogen with aniline blue staining. Partial least squares (PLS) were used to predict the standard analytical values of these polymers by the proposed methodology. Identification of the aerobic and anaerobic stages proved to be crucial for improving the assessment of PHA, PHB and PHV intracellular concentrations. Current Nile blue based methodology can be seen as a feasible starting point for further enhancement. Glycogen detection based on the developed aniline blue staining methodology combined with the image analysis data proved to be a promising technique, toward the elimination of the need for analytical off-line measurements.
Asunto(s)
Colorantes Fluorescentes/química , Glucógeno/análisis , Hidroxibutiratos/química , Fósforo , Poliésteres/química , Valeratos/química , Glucógeno/química , Análisis Multivariante , Oxazinas/química , Fósforo/química , Purificación del AguaRESUMEN
We report on the microwave spectrum of ethyl valerate, C(4)H(9)-COO-C(2)H(5), observed by molecular beam Fourier transform microwave spectroscopy (MB-FTMW). Highly accurate rotational and centrifugal distortion constants of the two most abundant conformers were determined. Their structure was investigated by comparison of the experimental rotational constants with those obtained by quantum chemical calculations. MP2/ 6-311++G(d,p) calculations failed to give a proper description of the observed conformers in the supersonic jet. Therefore, also other basis sets were tried using Hartree-Fock, second-order Møller-Plesset (MP2), and B3LYP methods to predict the observed gas-phase structures of the molecule. The quantum chemical results guided the conformer assignment of the rotational constants, obtained from the microwave experiment. One of the two observed conformers has C(s) symmetry, while the most abundant conformer has C(1) symmetry. The main conformer possesses a strong spectrum with high intensities. Additionally, harmonic frequency calculations at different levels of theory where carried out and a low lying vibration of the entire n-butyl group against the rest of the molecule was identified. The symbiotic interplay of microwave gas-phase investigations and quantum chemical calculations becomes evident in our results.
Asunto(s)
Frutas/química , Malus/química , Extractos Vegetales/análisis , Valeratos/química , Electrones , Gases , Enlace de Hidrógeno , Isomerismo , Microondas , Modelos Moleculares , Conformación Molecular , Teoría Cuántica , Rotación , Espectroscopía Infrarroja por Transformada de Fourier , VibraciónRESUMEN
The leucine metabolite, ß-hydroxy-ß-methylbutyrate (HMB), is a nutritional supplement that increases lean muscle and strength with exercise and in disease states. HMB is presently available as the Ca salt (CaHMB). The present study was designed to examine whether HMB in free acid gel form will improve HMB availability to tissues. Two studies were conducted and in each study four males and four females were given three treatments in a randomised, cross-over design. Treatments were CaHMB (gelatin capsule, 1 g), equivalent HMB free acid gel swallowed (FASW) and free acid gel held sublingual for 15 s then swallowed (FASL). Plasma HMB was measured for 3 h following treatment in study 1 and 24 h with urine collection in study 2. In both the studies, the times to peak plasma HMB were 128 (sem 11), 38 (sem 4) and 38 (sem 1) min (P < 0·0001) for CaHMB, FASW and FASL, respectively. The peak concentrations were 131 (sem 6), 249 (sem 14) and 239 (sem 14) µmol/l (P < 0·0001) for CaHMB, FASW and FASL, respectively. The areas under the curve were almost double for FASW and FASL (P < 0·0001). Daily urinary HMB excretion was not significantly increased resulting in more HMB retained (P < 0·003) with FASW and FASL. Half-lives were 3·17 (sem 0·22), 2·50 (sem 0·13) and 2·51 (sem 0·14) h for CaHMB, FASW and FASL, respectively (P < 0·004). Free acid gel resulted in quicker and greater plasma concentrations (+185%) and improved clearance (+25%) of HMB from plasma. In conclusion, HMB free acid gel could improve HMB availability and efficacy to tissues in health and disease.
Asunto(s)
Compuestos de Calcio/farmacocinética , Valeratos/farmacocinética , Adulto , Disponibilidad Biológica , Estudios Cruzados , Suplementos Dietéticos , Femenino , Geles , Humanos , Estudios Longitudinales , Masculino , Tasa de Depuración Metabólica , Sales (Química)/farmacocinética , Valeratos/sangre , Valeratos/química , Valeratos/orina , Adulto JovenRESUMEN
OBJECTIVES: This study investigated the relaxing effects of Valeriana officinalis L. (Valerianaceae) on human uterine muscle. The major uses of this species in Europe are as a sedative and an anxiolytic; it is also used as a spasmolytic to treat gastrointestinal spasm. METHODS: We evaluated two valerian extracts (ethanolic and aqueous) in comparison with a natural mixture of valepotriates and nifedipine on spontaneous and agonist-induced contractions in non-pregnant human myometrium in vitro. Qualitative and quantitative chemical analysis was used to correlate the chemical composition of extracts with their spasmolytic effects. Myometrial strips were obtained from hysterectomy specimens of premenopausal women. Longitudinal muscle strips were mounted vertically in tissue baths under physiological conditions to record their isometric contraction. The responses of cumulative concentrations of valerian extracts on spontaneous contractions in the presence and absence of the beta-adrenoceptor blocker atenolol or the cyclooxygenase inhibitor indometacin, and on agonist-induced contractions, were investigated. KEY FINDINGS: Valerian extracts and valepotriates inhibited uterine contractility in a concentration-dependent manner. Pretreatment with either atenolol or indometacin did not affect the uterine responses to valerian extracts. Valerian extract reduced the maximal contractile response induced by acetylcholine, phenylephrine and histamine independent of the stimulus. CONCLUSIONS: Valerian extracts may have direct inhibitory effects on the contractility of the human uterus and this justifies the traditional use of this plant in the treatment of uterine cramping associated with dysmenorrhoea.
Asunto(s)
Relajación Muscular/efectos de los fármacos , Relajación Muscular/fisiología , Miometrio/efectos de los fármacos , Extractos Vegetales/farmacología , Valeriana/química , Acetilcolina/antagonistas & inhibidores , Acetilcolina/farmacología , Antagonistas Adrenérgicos beta/administración & dosificación , Animales , Atenolol/administración & dosificación , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada/métodos , Relación Dosis-Respuesta a Droga , Epinefrina/antagonistas & inhibidores , Epinefrina/farmacología , Femenino , Cobayas , Humanos , Hidrazinas/metabolismo , Indenos/química , Indometacina/administración & dosificación , Iridoides/química , Contracción Muscular/fisiología , Miometrio/patología , Miometrio/fisiología , Nifedipino/farmacología , Extractos Vegetales/análisis , Extractos Vegetales/química , Raíces de Plantas/química , Premenopausia , Sesquiterpenos/química , Valeratos/química , Valeratos/aislamiento & purificación , Valeratos/farmacologíaRESUMEN
Phytochemical investigation of the leaves of Datura metel Linn. led to the isolation of a new pyrrole derivative 1 which was characterised as 2beta-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1'-methylethyl pentanoate on the basis of spectral data analyses and chemical reactions. Compound 1 was endowed with antifungal activity and its MIC was found to be 87.5 microg/ml. Two proteins having molecular weights of 42 and 58 kD of Aspergillus fumigatus are potential targets for compound 1.
Asunto(s)
Antifúngicos/química , Antifúngicos/farmacología , Datura/química , Pirroles/química , Pirroles/farmacología , Valeratos/química , Valeratos/farmacología , Antifúngicos/aislamiento & purificación , Aspergillus fumigatus/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Electroforesis en Gel de Poliacrilamida , Proteínas Fúngicas/efectos de los fármacos , Indicadores y Reactivos , Espectroscopía de Resonancia Magnética , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/química , Hojas de la Planta/química , Pirroles/aislamiento & purificación , Solventes , Espectrofotometría Infrarroja , Espectrofotometría Ultravioleta , Valeratos/aislamiento & purificaciónRESUMEN
Experimental studies with both synthetic and real domestic wastewater showed that poly-3-hydroxy-butyrate (3HB) and poly-3-hydroxy-valerate (3HV) formed in direct proportion to the acetate/propionate (Ace/Pro) ratio of the influent wastewater during Enhanced Biological Phosphorus Removal (EBPR). Acetic acid resulted in higher anaerobic phosphorus (P) release, polyhydroxyalkanoate (PHA) yield, 3HB content, and glycogen (CH) degradation. Linear regression showed that anaerobic P release (Prel) and CH degradation (CHdeg) were both a function of Ace-->3HB, but not of Pro-->3HV. Aerobic P uptake (Pup) correlated best with preceding Prel, rather than PHA (but note Prel correlated with Ace-->3HB). Aerobic CH formation (CHform) correlated best with CHdeg and 3HB. The results imply the acetate/propionate content of influent has a major influence on PHA, CH, and P transformations. Short-term increases in acetic or propionic acid increased Prel, but were always offset by corresponding changes in Pup to yield the same net P removal as the control reactor. Thus net P removal, and EBPR process performance, was probably a function of the population selected (i.e. XPAO fraction) during long-term cultivation.
Asunto(s)
Glucógeno/metabolismo , Hidroxibutiratos/análisis , Modelos Teóricos , Fósforo/aislamiento & purificación , Fósforo/metabolismo , Poliésteres/análisis , Valeratos/análisis , Eliminación de Residuos Líquidos/métodos , Purificación del Agua/métodos , Bacterias Anaerobias , Reactores Biológicos , Hidroxibutiratos/química , Poliésteres/química , Valeratos/químicaRESUMEN
Anaerobic-aerobic batch experiments indicated that poly-hydroxy-alkanoate (PHA) form was important in determining the net phosphorus removal resulting from different volatile fatty acids (VFAs). Poly-3-hydroxy-butyrate (3HB) content was found to correlate fairly well with higher observed aerobic phosphorus uptake per unit PHA carbon degraded. Poly-3-hydroxy-valerate (3HV) correlated with lower aerobic phosphorus uptakes per unit PHA carbon degraded. These experiments, conducted with synthetic wastewater, imply that VFA speciation might have a significant effect on aerobic phosphorus uptakes and net phosphorus removal. In addition, the model parameter fP.UPT (Barker and Dold, 1997) could vary with the proportion of acetic to propionic acid received (i.e., the acetic/propionic acid ratio may be an important parameter for these systems). Carbohydrate data implied that the lower aerobic phosphorus uptake resulting from 3HV might have been caused by a greater fraction of PHA carbon shunting to carbohydrate biosynthesis during aerobiosis.
Asunto(s)
Biomasa , Ácidos Grasos Volátiles/metabolismo , Fósforo/metabolismo , Poliésteres/metabolismo , Ácido Acético/farmacología , Aerobiosis , Anaerobiosis , Reactores Biológicos , Biotransformación/efectos de los fármacos , Carbohidratos/biosíntesis , Carbono/metabolismo , Hemiterpenos , Concentración de Iones de Hidrógeno , Hidroxibutiratos/química , Hidroxibutiratos/metabolismo , NAD/biosíntesis , Ácidos Pentanoicos/farmacología , Poliésteres/química , Propionatos/farmacología , Valeratos/química , Valeratos/metabolismo , Valeratos/farmacologíaRESUMEN
From the ethyl acetate extract of Asarum forbesii Maxin, four new constituents, asarumin A(I), B(II), C(III) and D(IV), were isolated along with elemicin (V), trans-asarone(VI) and linoleic acid(VII). The structures of the new compounds were elucidated as methyl 3 S-benzoyloxy-2 S-hydroxy-2-isopropylbutyrate for I, methyl 2 R-benzoyloxyisopentanoate for II, methyl 2 R-trans-cinnamoyloxyisopentanoate for III and methyl 2 R-piperonyloyloxyisopentanoate for IV. Compounds I, II, III and VII showed weak inhibition of PCA in rats, but the other compounds were inactive.